ibrutinib,zanubrutinib
beigene,janssen,Abbvie
['cll', 'zanu ']
would love to know:
- specific reasons for ibr d/c in those due to pt/dr choice
- median time to d/c of ibr vs zanu pts for reasons other than pd - availability/use of 2nd gen btki (ie acala) post ibr d/c pfs splits v early for low risk (med 1 prior line) r/r #cll cohort #ash22 
#Lymphoma #CLL specialist @OUHospitals
Hon. senior lecturer @UniofOxford
Low grade+elderly high grade UK NCRI grp member
UK #CLL forum exec committee 
#lymsm